Literature DB >> 16156851

Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily.

Karl S Peggs1, James P Allison.   

Abstract

The controlled orchestration of immune responses is a vital feature of cellular immunity in a system that must be able to reliably distinguish self from non-self. Contrary to early beliefs, peptide recognition by T cells exhibits a relatively high level of promiscuity. The requirement for a second signalling event to be present in addition to that provided by T cell receptor ligation for T cell activation to proceed helps to prevent inappropriately directed responses. An expanding array of co-stimulatory or inhibitory signalling receptors and ligands are now recognised to be involved in the control of the crucial decisions made determining the activation, expansion, and effector functions of responding cells, and ultimately the final targeting and execution of these functions. Tight regulation of the temporal and spatial organisation of receptor/ligand expression, combined with both forward and reverse signalling, endows an extraordinary elegance to these co-stimulatory pathways. The immunoglobulin superfamily occupies a central importance in this coordination of immune responses. The understanding of its relevance in a variety of physio-pathological circumstances is now yielding a number of potential targets for therapeutic manipulation, and such immunological molecular adjuvants are beginning to enter clinical trials.

Mesh:

Substances:

Year:  2005        PMID: 16156851     DOI: 10.1111/j.1365-2141.2005.05627.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  18 in total

Review 1.  Antibody-based immunotherapy of solid cancers: progress and possibilities.

Authors:  Christopher F Nicodemus
Journal:  Immunotherapy       Date:  2015-08-28       Impact factor: 4.196

Review 2.  Modification of accessory molecule signaling.

Authors:  Mary K Crow
Journal:  Springer Semin Immunopathol       Date:  2006-05-16

Review 3.  Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials.

Authors:  D L DiGiusto; L J N Cooper
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

4.  CD226 protein is involved in immune synapse formation and triggers Natural Killer (NK) cell activation via its first extracellular domain.

Authors:  Shengke Hou; Kuikui Ge; Xiaodong Zheng; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

5.  Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.

Authors:  Güllü Görgün; Elisabetta Calabrese; Ender Soydan; Teru Hideshima; Giulia Perrone; Madhavi Bandi; Diana Cirstea; Loredana Santo; Yiguo Hu; Yu-Tzu Tai; Sabikun Nahar; Naoya Mimura; Claire Fabre; Noopur Raje; Nikhil Munshi; Paul Richardson; Kenneth C Anderson
Journal:  Blood       Date:  2010-07-22       Impact factor: 22.113

6.  Expression of activated molecules on CD5(+)B lymphocytes in autoimmune hemolytic anemia.

Authors:  Hongli Zhu; Wenyan Xu; Hong Liu; Huaquan Wang; Rong Fu; Yuhong Wu; Wen Qu; Guojin Wang; Jing Guan; Jia Song; Limin Xing; Zonghong Shao
Journal:  Int J Hematol       Date:  2016-03-11       Impact factor: 2.490

Review 7.  NKT cell costimulation: experimental progress and therapeutic promise.

Authors:  Marianne J van den Heuvel; Nitan Garg; Luc Van Kaer; S M Mansour Haeryfar
Journal:  Trends Mol Med       Date:  2010-11-17       Impact factor: 11.951

Review 8.  Scianna: the lucky 13th blood group system.

Authors:  P A R Brunker; W A Flegel
Journal:  Immunohematology       Date:  2011

9.  Stimulation of naive CD8+ T cells by a variant viral epitope induces activation and enhanced apoptosis.

Authors:  Rebecca M Ream; Jie Sun; Thomas J Braciale
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

Review 10.  Biological messiness vs. biological genius: Mechanistic aspects and roles of protein promiscuity.

Authors:  William M Atkins
Journal:  J Steroid Biochem Mol Biol       Date:  2014-09-12       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.